<DOC>
	<DOCNO>NCT01890538</DOCNO>
	<brief_summary>This study aim investigate efficacy two different intravenous drug ( dimenhydrinate piracetam ) symptomatic management peripheral vertigo . The patient randomize two group accord symptomatic treatment modality : Dimenhydrinate ( 100 mg ) piracetam ( 2 g ) give 100 cc normal saline 30 minute . Each patient ask her/his vertigo symptom resolve , accord numeric rating scale ( 0=no vertigo , 10=worst possible vertigo ) . The patient rate intensity symptom follow time : - Numeric rating scale ( 1 10 ) : Admission - Numeric rating scale ( 1 10 ) : After study drug ( No ambulation ) * - Numeric rating scale ( 1 10 ) : After study drug ( Ambulation ) * - Ambulation refers head movement walk room , applicable .</brief_summary>
	<brief_title>Comparison Efficacy Between Piracetam Dimenhydrinate Patients With Peripheral Vertigo</brief_title>
	<detailed_description />
	<mesh_term>Vertigo</mesh_term>
	<mesh_term>Dizziness</mesh_term>
	<mesh_term>Dimenhydrinate</mesh_term>
	<criteria>Presenting emergency department vertigo symptom Adult patient ( 18 ) Agree participate study ( understand study protocol signing informed consent form ) Patients 18 year Patients diagnose ischemic/hemorrhagic stroke neuroimaging Patient diagnose transient ischemic attack Pregnants Patients take analgesic antihistaminic drug last 24 hour Documented declare allergy dimenhydrinate , piracetam benzodiazepine Patients agree participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>vertigo</keyword>
	<keyword>dimenhydrinate</keyword>
	<keyword>piracetam</keyword>
</DOC>